ID: ALA4875438

Max Phase: Preclinical

Molecular Formula: C27H36O3

Molecular Weight: 408.58

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)OCc3ccccc3)(CC1=O)C2

Standard InChI:  InChI=1S/C27H36O3/c1-24-14-10-21-25(2)12-7-13-26(3,23(29)30-17-19-8-5-4-6-9-19)20(25)11-15-27(21,18-24)16-22(24)28/h4-6,8-9,20-21H,7,10-18H2,1-3H3/t20-,21-,24-,25+,26+,27-/m0/s1

Standard InChI Key:  HOQJPWDEPMKPSG-FIVJYGDRSA-N

Associated Targets(Human)

Protein-tyrosine phosphatase 1B 8528 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Danio rerio 3092 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 408.58Molecular Weight (Monoisotopic): 408.2664AlogP: 6.10#Rotatable Bonds: 3
Polar Surface Area: 43.37Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.37CX LogD: 6.37
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.57Np Likeness Score: 2.08

References

1. Zhang H, Liu B, Xu G, Xu C, Ou E, Liu J, Sun X, Zhao Y..  (2021)  Synthesis and in vivo screening of isosteviol derivatives as new cardioprotective agents.,  219  [PMID:33862515] [10.1016/j.ejmech.2021.113396]
2. Li N, Li X, Deng M, Zhu F, Wang Z, Sheng R, Wu W, Guo R..  (2023)  Isosteviol derivatives as protein tyrosine Phosphatase-1B inhibitors: Synthesis, biological evaluation and molecular docking.,  83  [PMID:36963270] [10.1016/j.bmc.2023.117240]

Source